Preparation method of intrapleural hyperthermal infusion fluid

Abstract

The invention discloses a preparation method of intrapleural hyperthermal infusion fluid. The preparation method is characterized in that the intrapleural hyperthermal infusion fluid is prepared from the following raw material medicines: root and rhizome of Japanese false solomonseal, leaf of tasmanian bluegum, herb of denseflower bulbophyllum, mussel, fragrant sarcococca herb, cicada slough, motherwort fruit, sweet clover, kacmpferia galangal, princes-feather fruit and alga sgrgassi enerves. Proven by clinical experiments, the intrapleural hyperthermal infusion fluid disclosed by the invention has the characteristics of good curative effects and relatively high safety, and is worthy of being clinically applied and popularized.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a method for preparing thoracic perfusion fluid. Background technique [0002] Hyperthermic perfusion therapy is a new therapy for tumors treated by hyperthermia. Its principle is to use physical energy to heat the liquid and infuse it into the tumor site, so that the temperature of the tumor tissue rises to the effective treatment temperature and maintains it for a certain period of time. The difference in temperature tolerance can achieve the therapeutic purpose of making tumor cells apoptosis without damaging normal tissues. [0003] For tumor patients who have already developed cancerous pleural effusion, the pleural cavity is filled with fluid. It is a new idea and theory in recent years to perform hyperthermic pleural perfusion therapy while draining pleural effusion. At present, there are two main perfusion fluids for hyperthermic pleural perfusion therapy: on...

AI Technical Summary

Problems solved by technology

At present, there are two main perfusion fluids for hyperthermic pleural perfusion therapy: one is normal saline, which has poor timeliness in controlling pleural effusion and has a high recurrence rate; the other is chemotherapy drugs, such as cisplatin and nedaplatin, whose mechanism of action lies in the local Anti-cancer and promotion of pleural adhesions, but clinically, due to excessive adhesion promotion, a large amount of cellulose is deposited on the pleura, capillaries and fibroblasts in the pleura grow into the cellulose, become granulation tissue, and become thicker The dense, dense capsule forms an organized pleural fibrous plate, which wraps the lung tissue extensively and hard, lacks elasticity, restricts thoracic activity, severely reduces respiratory function, and increases the recurrence of pleural effusion.

[0004] Therefore, there is still a lack of clinically effective pleural perfusion fluid that can effectively improve respiratory function and reduce the recurrence rate.